RYTHM, Inc. — Form 8-K
Filed August 4, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 78/100
What the filing says
RYTHM reported Q2 2026 continuing operations revenue of $23.0M (up 73% sequentially from $13.3M in Q1), net income of $1.2M, and adjusted EBITDA of $6.4M. Cash position strengthened to $41.9M via $8.7M operating cash flow. Key driver: amended licensing deal with Green Thumb Industries imposing fixed $70M annual fees (effective April 1, 2026). However, management withheld Q3 guidance citing uncertainty from pending federal prohibition of hemp-derived THC products effective November 12, 2026—creating existential regulatory risk to core business model. Company has 2.2M shares outstanding; 11.0M warrants and 3.0M conversion shares also outstanding.
Why this rating
Strong operating momentum (73% growth, profitability return) is offset by looming November 2026 federal ban on hemp THC—existential threat to hemp-beverage revenue stream. Regulatory cliff materially outweighs Q2 beat. Relative to $26.7M market cap, $70M GTI licensing commitment is material leverage. No Q3 guidance signals management alarm.
See more from August 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.